Posts by Natalie McCormick, PhD
-
Study Positions SGLT2 Inhibitors as Gout Treatment
A Massachusetts General Hospital research team has found that SGLT2 inhibitor therapy reduces gout flares and lowers the risk of myocardial infarction in patients with diabetes.
-
Review: Cardiometabolic–Renal Comorbidities in Gout
Hyon K. Choi, MD, Chio Yokose, MD, MS, and Natalie McCormick, PhD, of the Division of Rheumatology, Allergy and Immunology, suggest pharmacologic agents that can both lower urate levels in patients with gout and treat common cardiometabolic-renal comorbidities of the disease.
Biography
Natalie McCormick, PhD, is a research fellow in the Division of Rheumatology, Allergy and Immunology at Massachusetts General Hospital.
Rheumatology, Allergy and Immunology
The Division of Rheumatology, Allergy and Immunology at Massachusetts General Hospital provides leading-edge treatment and transformative care to patients with rheumatic disease and autoimmune conditions.